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IDENTIFYING THE KEY ENZYMES INVOLVED IN MATRIPTASE-INDUCED
CARTILAGE AGGRECAN AND COLLAGEN RESORPTION
D.J. Wilkinson, D. Rowan, J. Milner. Musculoskeletal Res. Group, Newcastle
upon Tyne, United Kingdom
Purpose: Serine proteases interact with the matrix metalloproteases
(MMPs) in the cascades leading to the proteolytic degradation of cartilage
that occurs in osteoarthritis (OA). We have previously identiﬁed elevated
expression of the type II transmembrane serine protease, matriptase, in OA
cartilage and shown that it is an initiator of cartilage collagen resorption
via the induction and activation of proMMPs. The aim of this study was to
further investigate the mechanism of action of matriptase in inducing
cartilage resorption by measuring temporal expression of both MMPs and
A Disintegrin and Metalloprotease with Thrombospondin Repeats (ADAM
TS) in matriptase-induced resorbing cartilage. Furthermore, we investigate
the role of matriptase in the breakdown of aggrecan, the most abundant
proteoglycan in cartilage. We also describe in vitro analysis of a potent
inhibitor of matriptase.
Methods: Human OA cartilage in explant culture was stimulated with
recombinant matriptase. Collagen and proteoglycan breakdown were
assessed by analysing the levels of hydroxyproline and glycosaminoglycan
(GAG), respectively. For gene expression studies, RNA was extracted from
cartilage explant culture, reverse transcribed and real-time PCR was per-
formed. Active collagenase levels were determined using H3 collagen in
a bioassay format. MMP1 and MMP13 were measured by ELISA. In order to
determine if matriptase could directly degrade cartilage proteoglycan,
cartilage was freeze-thawed prior to stimulation. Conditionedmedia taken
from stimulated explant culture was used for western blotting. These blots
were probed with antibodies speciﬁc for neo-epitopes generated by MMP
or aggrecanase degraded aggrecan (BC-14 and BC-3, respectively). Kinetic
analysis of a matriptase inhibitor towards matriptase and other serine
proteases were monitored using the synthetic ﬂuorogenic substrate Boc-
QAR-AMC, in a standard ﬂuorometer and analysed using GraphPad Prism 5
software.
Results: Here we demonstrate that matriptase causes a rapid induction of
MMP1, MMP13 and to a lesser extent ADAM TS4 gene expression. This
correlates with a gradual increase in active collagenase levels, MMP-1 and
MMP-13 and the subsequent breakdown of proteoglycan and collagen. The
addition of matriptase to freeze-thawed cartilage did not induce proteo-
glycan resorption demonstrating that matriptase does not directly degrade
this matrix component. Matriptase-induced proteoglycan breakdown is
metalloprotease dependent as the addition of GM6001, a metalloprotease
inhibitor completely blocked resorption. Neoepitope antibodies directed
towards MMP and aggrecanase cleavage revealed that MMP activity is
largely responsible for this proteoglycan breakdown. In vitro analysis of
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compared to other trypsin-like serine proteases.
Conclusions: Building on evidence that matriptase acts as a novel initiator
of cartilage collagen destruction, these new data show that it can also
potently degrade cartilage proteoglycan by induction of MMPs and
ADAMTS4. We have demonstrated that this breakdown is largely due to
the activity of MMPs. The matriptase inhibitor appears to be potent and
selective towards matriptase and represents a valid start point for drug
development in OA.
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GLYCAN MAPPING AND GALECTIN-1 EXPRESSION IN OSTEOARTHRITIC
CARTILAGE
S. Toegel 1, D. Bieder 1, S.M. Walzer 1, M. Lohr 2, H. Kaltner 2, H.-J. Gabius 2,
R. Windhager 1. 1Med. Univ. of Vienna, Vienna, Austria; 2 Ludwig-
Maximilians-Univ., Munich, Germany
Purpose: The glycosylation of cells and tissues is a complex process that
contributes to the adhesion capacity of cells and potentially affects cellular
signal transduction or the onset of apoptosis. In this context, the glycan-
encoded information may be translated into a biological effect by endog-
enous lectins such as galectins.
Despite the signiﬁcance of glycoproteins for the maintainance of cartilage
functionality, the potential implications of the chondrocyte glycophenotype
in the pathophysiology of osteoarthritis (OA) remain largely unknown.
The present study aimed to assess the glycan proﬁle and the expression of
Galectin-1 in human OA cartilage and to determine the effect of Galectin-1
on primary chondrocytes in vitro.
Methods: Cartilage specimens were collected from OA patients under-
going knee replacement surgery (n¼10) prior to processing for immuno-
histochemistry. Following staining with safranin-O, the grade of cartilage
degeneration was deﬁned in 90 histological sections using the Mankin
degeneration score. Using a panel of 11 plant lectins, common constituents
of natural glycans, serving as ligands for endogenous lectins (galectins),
were attributed to the tissue sections. Histochemical analysis of Galectin-1
binding sites was accomplished using biotinylated human Galectin-1. The
number of Galectin-1 positive chondrocytes was evaluated in cartilage
specimens as a function of the degeneration score. The biological effect of
Galectin-1 on isolated primary human chondrocytes was determined
using RT-qPCR and ELISA assays.
Results: The intensity of plant lectin staining was subject to the grade of
cartilage degeneration. Cartilage tissues with a high Mankin score were
characterized by strong plant lectin staining indicating the expression of
functional glycan epitopes in degenerated cartilage. Moreover, binding
sites for Galectin-1 were detected in OA cartilage. Importantly, a signiﬁcant
correlation was revealed between the number of Galectin-1 positive
chondrocytes and the degeneration score (r¼0.71). RT-qPCR and ELISA
assays demonstrated that Galectin-1 strongly upregulated Interleukin-1ß
as well as Matrix metalloproteinase-3 and -13 mRNA and protein levels in
cultured chondrocytes.
Conclusions: Viewing OA from a glycobiological perspective, we found that
the expression of glycan epitopes was signiﬁcantly more pronounced in
highly degenerated OA cartilage as compared to intact cartilage. Of note, the
expression of Galectin-1 by chondrocytes correlated with the cartilage
degeneration score, indicating the potential translation of the sugar code
into biological effects. In this context, we demonstrated Galectin-1 binding
sites in OA cartilage and showed that Galectin-1 induced catabolic processes
in chondrocytes in vitro. In summary, this study suggests a role for altered
glycan proﬁles and Galectin-1 expression in OA disease progression.
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CARTILAGE DAMAGE IN VIVO AND IN VITRO REGULATES MOLECULES
THAT DRIVE PAIN IN MURINE OSTEOARTHRITIS
A. Chanalaris 1, C.B. Knights 2, K.W. Chong 1, C. Driscoll 1, C. Gentry 2,
S. Bevan 2, T.L. Vincent 1. 1Kennedy Inst. of Rheumatology, London, United
Kingdom; 2Wolfson Ctr. for Age-Related Diseases, London, United Kingdom
Purpose: Pain is the main symptom of osteoarthritis (OA), but it is
currently unknownwhich tissues give rise to pain and what drives it in OA.Our previous studies in painful behaviour in mice following surgical
induction of OA revealed that mice develop pain at around 8 weeks post-
surgery. At this time there ismoderate cartilage damage, but little synovitis
in the joint. The aim of this study was to identify which pain pathways are
activated in painful OA joints, in which tissues are these pathways acti-
vated, and what is driving them.
Methods: Partial meniscectomy or sham operation was performed in 10
week old female C57B6 mice. Pain assessments were performed weekly.
RNA was isolated from whole knee joints, or from micro-dissected tissues
(articular cartilage, meniscus and tibial epiphysis). For cartilage injury
responses in vitro, RNA was isolated from hip epiphyses of 5 week old
mice, at 0 and 4h post-explantation. RT-PCR was performed using
Taqman Low Density Arrays for 67 genes that are involved in inﬂam-
mation and pain.
Results: Pain developed 8 weeks after partial menisectomy. Bradykinin
receptors (BDKRB1 and 2), protachykinin (TAC1), tachykinin receptor 1
(TACR1), nerve growth factor (NGF), neuropeptide Y (NPY) and CCL21were
the only genes upregulated in the whole joint compared to sham operated
joints from the panel of 67 genes. When we examined the microdissected
tissues we found that the same genes, apart from BDKRB2 and NPY, were
upregulated in cartilage. BDKRB2 was upregulated in the epiphysis. NPY
was not regulated in anyof themicrodissected tissues. To establishwhether
cartilage injury per se could induce these same genes, we looked at the
regulation of pain related genes in explanted murine hips. NGF, BDKRB1/2,
TAC1 and NPY were strongly regulated upon cartilage injury in vitro.
Conclusions: This study has revealed a number of important observations:
 A select group of pain mediators and receptors are regulated in
the joint when meniscectomised mice develop pain.
 Expression of these mediators and receptors is occurring in
a non-inﬂamed joint, and is not associated with expression of
other inﬂammatory molecules.
 The majority of these pain mediators and receptors are
expressed in the damaged cartilage in vivo and regulated by
cartilage injury in vitro.227
THE MOLECULAR RESPONSE TO ACUTE JOINT DESTABILISATION IS
ALTERED IN FEMALE COMPARED TO MALE MICE.
C. Driscoll, A. Burleigh, A. Chanalaris, J. Saklatvala, T.L. Vincent. Kennedy
Inst. of Rheumatology, London, United Kingdom
Purpose: It is well established that gender is an independent risk factor for
the development of osteoarthritis (OA). Human epidemiological studies
have highlighted the increased incidence of disease in women after the age
of 50 years. This postmenopausal increase in OA has been attributed to
changes in sex hormones, and has led to the suggestion that estrogen has
chondro-protective effects. This is supported by the observation that the
disease severity of surgically induced OA in female pre-menopausal mice is
signiﬁcantly lower than in males, and that in female mice it is increased
following oophorectomy. The effect of sex hormones onOA severity could be
at the level of the joint tissues themselves, or could be indirect by affecting
other factors such as levels of physical activity. The aimof this project was to
investigate the mechanisms by which gender affects severity of OA.
Methods: OAwas induced in 10 week old male and female C57B/6 mice by
destabilisation of the medial meniscus (DMM). OA was assessed by
histological assessment of the joints at 4, 8 and 12 weeks post DMM or
sham surgery. Activity levels in mice were assessed using LABORAS
(Laboratory Animal Behaviour Observation Registration and Analysis
System) which is able to distinguish different types of activity (running,
eating, climbing, resting). Pain assessments were performed using The
Linton incapacitance tester (which measures differential weight born
through the operated compared to non-operated joints). RNA was
extracted frommouse knee joints for RT-PCR analysis 6h following surgery
to determine whether gender inﬂuences the molecular response to acute
joint destabilisation.
Results: Histological analysis conﬁrmed previous studies demonstrating
an increase in severity of OA in male compared to female mice at 4, 8 and
